Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 24, 2007

BioNanomatrix and Princeton Univ. Receive NCI Support for Cell Fractionation Nanofluidics Tool

  • BioNanomatrix and Princeton University received a two-year, $200,000 Small Technology Transfer Research grant from the NCI. The funding will be used to develop an integrated fluidics systems for the front-end sample sorting component of the BioNanomatrix whole genome analytical platform.

    BioNanomatrix says that it is developing tools that enable nanoscale single molecule identification and analysis of the entire genome, delivering single molecule sensitivity in a highly parallel format. The goal of the current NCI-backed project is to create integrated systems that can separate out and sort whole chromosomes from a single cell or multiple cells.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »